Global Acute Migraine Drugs Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
SKU ID : QYR-18738085 | Publishing Date : 13-Jul-2021 | No. of pages : 118
Detailed TOC of Global Acute Migraine Drugs Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
1 Acute Migraine Drugs Market Overview1.1 Acute Migraine Drugs Product Overview
1.2 Acute Migraine Drugs Market Segment by Type
1.2.1 Triptans
1.2.2 NSAIDs
1.2.3 Others
1.3 Global Acute Migraine Drugs Market Size by Type
1.3.1 Global Acute Migraine Drugs Market Size Overview by Type (2016-2027)
1.3.2 Global Acute Migraine Drugs Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Acute Migraine Drugs Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Acute Migraine Drugs Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Acute Migraine Drugs Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Acute Migraine Drugs Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Acute Migraine Drugs Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Acute Migraine Drugs Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Acute Migraine Drugs Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Acute Migraine Drugs Sales Breakdown by Type (2016-2021)
1.4.2 Europe Acute Migraine Drugs Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Acute Migraine Drugs Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Acute Migraine Drugs Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Acute Migraine Drugs Sales Breakdown by Type (2016-2021)
2 Global Acute Migraine Drugs Market Competition by Company
2.1 Global Top Players by Acute Migraine Drugs Sales (2016-2021)
2.2 Global Top Players by Acute Migraine Drugs Revenue (2016-2021)
2.3 Global Top Players Acute Migraine Drugs Price (2016-2021)
2.4 Global Top Manufacturers Acute Migraine Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Acute Migraine Drugs Market Competitive Situation and Trends
2.5.1 Acute Migraine Drugs Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Acute Migraine Drugs Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Acute Migraine Drugs as of 2020)
2.7 Date of Key Manufacturers Enter into Acute Migraine Drugs Market
2.8 Key Manufacturers Acute Migraine Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Acute Migraine Drugs Status and Outlook by Region
3.1 Global Acute Migraine Drugs Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Acute Migraine Drugs Historic Market Size by Region
3.2.1 Global Acute Migraine Drugs Sales in Volume by Region (2016-2021)
3.2.2 Global Acute Migraine Drugs Sales in Value by Region (2016-2021)
3.2.3 Global Acute Migraine Drugs Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Acute Migraine Drugs Forecasted Market Size by Region
3.3.1 Global Acute Migraine Drugs Sales in Volume by Region (2022-2027)
3.3.2 Global Acute Migraine Drugs Sales in Value by Region (2022-2027)
3.3.3 Global Acute Migraine Drugs Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Acute Migraine Drugs by Application
4.1 Acute Migraine Drugs Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Drug Stores
4.2 Global Acute Migraine Drugs Market Size by Application
4.2.1 Global Acute Migraine Drugs Market Size Overview by Application (2016-2027)
4.2.2 Global Acute Migraine Drugs Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Acute Migraine Drugs Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Acute Migraine Drugs Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Acute Migraine Drugs Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Acute Migraine Drugs Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Acute Migraine Drugs Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Acute Migraine Drugs Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Acute Migraine Drugs Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Acute Migraine Drugs Sales Breakdown by Application (2016-2021)
4.3.2 Europe Acute Migraine Drugs Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Acute Migraine Drugs Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Acute Migraine Drugs Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Acute Migraine Drugs Sales Breakdown by Application (2016-2021)
5 North America Acute Migraine Drugs by Country
5.1 North America Acute Migraine Drugs Historic Market Size by Country
5.1.1 North America Acute Migraine Drugs Sales in Volume by Country (2016-2021)
5.1.2 North America Acute Migraine Drugs Sales in Value by Country (2016-2021)
5.2 North America Acute Migraine Drugs Forecasted Market Size by Country
5.2.1 North America Acute Migraine Drugs Sales in Volume by Country (2022-2027)
5.2.2 North America Acute Migraine Drugs Sales in Value by Country (2022-2027)
6 Europe Acute Migraine Drugs by Country
6.1 Europe Acute Migraine Drugs Historic Market Size by Country
6.1.1 Europe Acute Migraine Drugs Sales in Volume by Country (2016-2021)
6.1.2 Europe Acute Migraine Drugs Sales in Value by Country (2016-2021)
6.2 Europe Acute Migraine Drugs Forecasted Market Size by Country
6.2.1 Europe Acute Migraine Drugs Sales in Volume by Country (2022-2027)
6.2.2 Europe Acute Migraine Drugs Sales in Value by Country (2022-2027)
7 Asia-Pacific Acute Migraine Drugs by Region
7.1 Asia-Pacific Acute Migraine Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Acute Migraine Drugs Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Acute Migraine Drugs Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Acute Migraine Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Acute Migraine Drugs Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Acute Migraine Drugs Sales in Value by Region (2022-2027)
8 Latin America Acute Migraine Drugs by Country
8.1 Latin America Acute Migraine Drugs Historic Market Size by Country
8.1.1 Latin America Acute Migraine Drugs Sales in Volume by Country (2016-2021)
8.1.2 Latin America Acute Migraine Drugs Sales in Value by Country (2016-2021)
8.2 Latin America Acute Migraine Drugs Forecasted Market Size by Country
8.2.1 Latin America Acute Migraine Drugs Sales in Volume by Country (2022-2027)
8.2.2 Latin America Acute Migraine Drugs Sales in Value by Country (2022-2027)
9 Middle East and Africa Acute Migraine Drugs by Country
9.1 Middle East and Africa Acute Migraine Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Acute Migraine Drugs Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Acute Migraine Drugs Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Acute Migraine Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Acute Migraine Drugs Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Acute Migraine Drugs Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Acute Migraine Drugs Business
10.1 GSK
10.1.1 GSK Corporation Information
10.1.2 GSK Introduction and Business Overview
10.1.3 GSK Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
10.1.4 GSK Acute Migraine Drugs Products Offered
10.1.5 GSK Recent Development
10.2 Teva
10.2.1 Teva Corporation Information
10.2.2 Teva Introduction and Business Overview
10.2.3 Teva Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Teva Acute Migraine Drugs Products Offered
10.2.5 Teva Recent Development
10.3 Pfizer
10.3.1 Pfizer Corporation Information
10.3.2 Pfizer Introduction and Business Overview
10.3.3 Pfizer Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Pfizer Acute Migraine Drugs Products Offered
10.3.5 Pfizer Recent Development
10.4 Novartis
10.4.1 Novartis Corporation Information
10.4.2 Novartis Introduction and Business Overview
10.4.3 Novartis Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Novartis Acute Migraine Drugs Products Offered
10.4.5 Novartis Recent Development
10.5 Sun Pharma
10.5.1 Sun Pharma Corporation Information
10.5.2 Sun Pharma Introduction and Business Overview
10.5.3 Sun Pharma Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Sun Pharma Acute Migraine Drugs Products Offered
10.5.5 Sun Pharma Recent Development
10.6 Grunenthal
10.6.1 Grunenthal Corporation Information
10.6.2 Grunenthal Introduction and Business Overview
10.6.3 Grunenthal Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Grunenthal Acute Migraine Drugs Products Offered
10.6.5 Grunenthal Recent Development
10.7 Endo Pharmaceuticals
10.7.1 Endo Pharmaceuticals Corporation Information
10.7.2 Endo Pharmaceuticals Introduction and Business Overview
10.7.3 Endo Pharmaceuticals Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Endo Pharmaceuticals Acute Migraine Drugs Products Offered
10.7.5 Endo Pharmaceuticals Recent Development
10.8 Merck
10.8.1 Merck Corporation Information
10.8.2 Merck Introduction and Business Overview
10.8.3 Merck Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Merck Acute Migraine Drugs Products Offered
10.8.5 Merck Recent Development
10.9 J & J
10.9.1 J & J Corporation Information
10.9.2 J & J Introduction and Business Overview
10.9.3 J & J Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
10.9.4 J & J Acute Migraine Drugs Products Offered
10.9.5 J & J Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Acute Migraine Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Acute Migraine Drugs Industrial Chain Analysis
11.4 Acute Migraine Drugs Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Acute Migraine Drugs Distributors
12.3 Acute Migraine Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Figures, Tables and Charts Available in Global Acute Migraine Drugs Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
List of TablesTable 1. Major Company of Triptans
Table 2. Major Company of NSAIDs
Table 3. Major Company of Others
Table 4. Global Acute Migraine Drugs Sales by Type 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Acute Migraine Drugs Sales by Type (2016-2021) & (K Unit)
Table 6. Global Acute Migraine Drugs Sales Market Share in Volume by Type (2016-2021)
Table 7. Global Acute Migraine Drugs Sales by Type (2016-2021) & (US& Million)
Table 8. Global Acute Migraine Drugs Market Share in Value by Type (2016-2021)
Table 9. Global Acute Migraine Drugs Price by Type (2016-2021) & (USD/Unit)
Table 10. Global Acute Migraine Drugs Sales by Type (2022-2027) & (K Unit)
Table 11. Global Acute Migraine Drugs Sales Market Share in Volume by Type (2022-2027)
Table 12. Global Acute Migraine Drugs Sales by Type (2022-2027) & (US$ Million)
Table 13. Global Acute Migraine Drugs Sales Market Share in Value by Type (2022-2027)
Table 14. Global Acute Migraine Drugs Price by Type (2022-2027) & (USD/Unit)
Table 15. North America Acute Migraine Drugs Sales by Type (2016-2021) & (K Unit)
Table 16. North America Acute Migraine Drugs Sales by Type (2016-2021) & (US$ Million)
Table 17. Europe Acute Migraine Drugs Sales (K Unit) by Type (2016-2021)
Table 18. Europe Acute Migraine Drugs Sales by Type (2016-2021) & (US$ Million)
Table 19. Asia-Pacific Acute Migraine Drugs Sales (K Unit) by Type (2016-2021)
Table 20. Asia-Pacific Acute Migraine Drugs Sales by Type (2016-2021) & (US$ Million)
Table 21. Latin America Acute Migraine Drugs Sales (K Unit) by Type (2016-2021)
Table 22. Latin America Acute Migraine Drugs Sales by Type (2016-2021) & (US$ Million)
Table 23. Middle East and Africa Acute Migraine Drugs Sales (K Unit) by Type (2016-2021)
Table 24. Middle East and Africa Acute Migraine Drugs Sales by Type (2016-2021) & (US$ Million)
Table 25. Global Acute Migraine Drugs Sales by Company (2016-2021) & (K Unit)
Table 26. Global Acute Migraine Drugs Sales Share by Company (2016-2021)
Table 27. Global Acute Migraine Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 28. Global Acute Migraine Drugs Revenue Share by Company (2016-2021)
Table 29. Global Market Acute Migraine Drugs Price by Company (2016-2021) & (USD/Unit)
Table 30. Global Acute Migraine Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Acute Migraine Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Acute Migraine Drugs as of 2020
Table 33. Date of Key Manufacturers Enter into Acute Migraine Drugs Market
Table 34. Key Manufacturers Acute Migraine Drugs Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Acute Migraine Drugs Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027
Table 37. Global Acute Migraine Drugs Sales by Region (2016-2021) & (K Unit)
Table 38. Global Acute Migraine Drugs Sales Market Share in Volume by Region (2016-2021)
Table 39. Global Acute Migraine Drugs Sales by Region (2016-2021) & (US$ Million)
Table 40. Global Acute Migraine Drugs Sales Market Share in Value by Region (2016-2021)
Table 41. Global Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 42. Global Acute Migraine Drugs Sales by Region (2022-2027) & (K Unit)
Table 43. Global Acute Migraine Drugs Sales Market Share in Volume by Region (2022-2027)
Table 44. Global Acute Migraine Drugs Sales by Region (2022-2027) & (US$ Million)
Table 45. Global Acute Migraine Drugs Sales Market Share in Value by Region (2022-2027)
Table 46. Global Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2022-2027)
Table 47. Global Acute Migraine Drugs Sales by Application: 2016 VS 2021 VS 2027 (US$ Million)
Table 48. Global Acute Migraine Drugs Sales by Application (2016-2021) & (K Unit)
Table 49. Global Acute Migraine Drugs Sales Market Share in Volume by Application (2016-2021)
Table 50. Global Acute Migraine Drugs Sales by Application (2016-2021) & (US$ Million)
Table 51. Global Acute Migraine Drugs Sales Market Share in Value by Application (2016-2021)
Table 52. Global Acute Migraine Drugs Price by Application (2016-2021) & (USD/Unit)
Table 53. Global Acute Migraine Drugs Sales by Application (2022-2027) & (K Unit)
Table 54. Global Acute Migraine Drugs Sales Market Share in Volume by Application (2022-2027)
Table 55. Global Acute Migraine Drugs Sales by Application (2022-2027) & (US$ Million)
Table 56. Global Acute Migraine Drugs Sales Market Share in Value by Application (2022-2027)
Table 57. Global Acute Migraine Drugs Price by Application (2022-2027) & (USD/Unit)
Table 58. North America Acute Migraine Drugs Sales by Application (2016-2021) (K Unit)
Table 59. North America Acute Migraine Drugs Sales by Application (2016-2021) & (US$ Million)
Table 60. North America Acute Migraine Drugs Sales Market Share in Value by Application in 2020
Table 61. Europe Acute Migraine Drugs Sales by Application (2016-2021) (K Unit)
Table 62. Europe Acute Migraine Drugs Sales by Application (2016-2021) & (US$ Million)
Table 63. Europe Acute Migraine Drugs Sales Market Share in Value by Application in 2020
Table 64. Asia-Pacific Acute Migraine Drugs Sales by Application (2016-2021) (K Unit)
Table 65. Asia-Pacific Acute Migraine Drugs Sales by Application (2016-2021) & (US$ Million)
Table 66. Asia-Pacific Acute Migraine Drugs Sales Market Share in Value by Application in 2020
Table 67. Latin America Acute Migraine Drugs Sales by Application (2016-2021) (K Unit)
Table 68. Latin America Acute Migraine Drugs Sales by Application (2016-2021) & (US$ Million)
Table 69. Latin America Acute Migraine Drugs Sales Market Share in Value by Application in 2020
Table 70. Middle East and Africa Acute Migraine Drugs Sales by Application (2016-2021) (K Unit)
Table 71. Middle East and Africa Acute Migraine Drugs Sales by Application (2016-2021) & (US$ Million)
Table 72. Middle East and Africa Acute Migraine Drugs Sales Market Share in Value by Application in 2020
Table 73. North America Acute Migraine Drugs Sales by Country (2016-2021) & (K Unit)
Table 74. North America Acute Migraine Drugs Sales Market Share in Volume by Country (2016-2021)
Table 75. North America Acute Migraine Drugs Sales by Country (2016-2021) & (US$ Million)
Table 76. North America Acute Migraine Drugs Sales Market Share in Value by Country (2016-2021)
Table 77. North America Acute Migraine Drugs Sales by Country (2022-2027) & (K Unit)
Table 78. North America Acute Migraine Drugs Sales Market Share in Volume by Country (2022-2027)
Table 79. North America Acute Migraine Drugs Sales by Country (2022-2027) & (US$ Million)
Table 80. North America Acute Migraine Drugs Sales Market Share in Value by Country (2022-2027)
Table 81. Europe Acute Migraine Drugs Sales by Country (2016-2021) & (K Unit)
Table 82. Europe Acute Migraine Drugs Sales Market Share in Volume by Country (2016-2021)
Table 83. Europe Acute Migraine Drugs Sales by Country (2016-2021) & (US$ Million)
Table 84. Europe Acute Migraine Drugs Sales Market Share in Value by Country (2016-2021)
Table 85. Europe Acute Migraine Drugs Sales by Country (2022-2027) & (K Unit)
Table 86. Europe Acute Migraine Drugs Sales Market Share in Volume by Country (2022-2027)
Table 87. Europe Acute Migraine Drugs Sales by Country (2022-2027) & (US$ Million)
Table 88. Europe Acute Migraine Drugs Sales Market Share in Value by Country (2022-2027)
Table 89. Asia-Pacific Acute Migraine Drugs Sales by Region (2016-2021) & (K Unit)
Table 90. Asia-Pacific Acute Migraine Drugs Sales Market Share in Volume by Region (2016-2021)
Table 91. Asia-Pacific Acute Migraine Drugs Sales by Region (2016-2021) & (US$ Million)
Table 92. Asia-Pacific Acute Migraine Drugs Sales Market Share in Value by Region (2016-2021)
Table 93. Asia-Pacific Acute Migraine Drugs Sales by Region (2022-2027) & (K Unit)
Table 94. Asia-Pacific Acute Migraine Drugs Sales Market Share in Volume by Region (2022-2027)
Table 95. Asia-Pacific Acute Migraine Drugs Sales by Region (2022-2027) & (US$ Million)
Table 96. Asia-Pacific Acute Migraine Drugs Sales Market Share in Value by Region (2022-2027)
Table 97. Latin America Acute Migraine Drugs Sales by Country (2016-2021) & (K Unit)
Table 98. Latin America Acute Migraine Drugs Sales Market Share in Volume by Country (2016-2021)
Table 99. Latin America Acute Migraine Drugs Sales by Country (2016-2021) & (US$ Million)
Table 100. Latin America Acute Migraine Drugs Sales Market Share in Value by Country (2016-2021)
Table 101. Latin America Acute Migraine Drugs Sales by Country (2022-2027) & (K Unit)
Table 102. Latin America Acute Migraine Drugs Sales Market Share in Volume by Country (2022-2027)
Table 103. Latin America Acute Migraine Drugs Sales by Country (2022-2027) & (US$ Million)
Table 104. Latin America Acute Migraine Drugs Sales Market Share in Value by Country (2022-2027)
Table 105. Middle East and Africa Acute Migraine Drugs Sales by Country (2016-2021) & (K Unit)
Table 106. Middle East and Africa Acute Migraine Drugs Sales Market Share in Volume by Country (2016-2021)
Table 107. Middle East and Africa Acute Migraine Drugs Sales by Country (2016-2021) & (US$ Million)
Table 108. Middle East and Africa Acute Migraine Drugs Sales Market Share in Value by Country (2016-2021)
Table 109. Middle East and Africa Acute Migraine Drugs Sales by Country (2022-2027) & (K Unit)
Table 110. Middle East and Africa Acute Migraine Drugs Sales Market Share in Volume by Country (2022-2027)
Table 111. Middle East and Africa Acute Migraine Drugs Sales by Country (2022-2027) & (US$ Million)
Table 112. Middle East and Africa Acute Migraine Drugs Sales Market Share in Value by Country (2022-2027)
Table 113. GSK Corporation Information
Table 114. GSK Introduction and Business Overview
Table 115. GSK Acute Migraine Drugs Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 116. GSK Acute Migraine Drugs Product
Table 117. GSK Recent Development
Table 118. Teva Corporation Information
Table 119. Teva Introduction and Business Overview
Table 120. Teva Acute Migraine Drugs Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 121. Teva Acute Migraine Drugs Product
Table 122. Teva Recent Development
Table 123. Pfizer Corporation Information
Table 124. Pfizer Introduction and Business Overview
Table 125. Pfizer Acute Migraine Drugs Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 126. Pfizer Acute Migraine Drugs Product
Table 127. Pfizer Recent Development
Table 128. Novartis Corporation Information
Table 129. Novartis Introduction and Business Overview
Table 130. Novartis Acute Migraine Drugs Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 131. Novartis Acute Migraine Drugs Product
Table 132. Novartis Recent Development
Table 133. Sun Pharma Corporation Information
Table 134. Sun Pharma Introduction and Business Overview
Table 135. Sun Pharma Acute Migraine Drugs Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 136. Sun Pharma Acute Migraine Drugs Product
Table 137. Sun Pharma Recent Development
Table 138. Grunenthal Corporation Information
Table 139. Grunenthal Introduction and Business Overview
Table 140. Grunenthal Acute Migraine Drugs Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 141. Grunenthal Acute Migraine Drugs Product
Table 142. Grunenthal Recent Development
Table 143. Endo Pharmaceuticals Corporation Information
Table 144. Endo Pharmaceuticals Introduction and Business Overview
Table 145. Endo Pharmaceuticals Acute Migraine Drugs Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 146. Endo Pharmaceuticals Acute Migraine Drugs Product
Table 147. Endo Pharmaceuticals Recent Development
Table 148. Merck Corporation Information
Table 149. Merck Introduction and Business Overview
Table 150. Merck Acute Migraine Drugs Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 151. Merck Acute Migraine Drugs Product
Table 152. Merck Recent Development
Table 153. J & J Corporation Information
Table 154. J & J Introduction and Business Overview
Table 155. J & J Acute Migraine Drugs Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 156. J & J Acute Migraine Drugs Product
Table 157. J & J Recent Development
Table 158. Key Raw Materials Lists
Table 159. Raw Materials Key Suppliers Lists
Table 160. Acute Migraine Drugs Market Trends
Table 161. Acute Migraine Drugs Market Drivers
Table 162. Acute Migraine Drugs Market Challenges
Table 163. Acute Migraine Drugs Market Restraints
Table 164. Acute Migraine Drugs Distributors List
Table 165. Acute Migraine Drugs Downstream Customers
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Acute Migraine Drugs Product Picture
Figure 2. Global Acute Migraine Drugs Market Size, 2016 VS 2021 VS 2027 (US$ Million)
Figure 3. Global Acute Migraine Drugs Market Size Status and Outlook (2016-2027) & (US$ Million)
Figure 4. Global Acute Migraine Drugs Sales Status and Outlook (2016-2027) & (K Unit)
Figure 5. Product Picture of Triptans
Figure 6. Global Triptans Sales YoY Growth (2016-2021) & (K Unit)
Figure 7. Product Picture of NSAIDs
Figure 8. Global NSAIDs Sales YoY Growth (2016-2021) & (K Unit)
Figure 9. Product Picture of Others
Figure 10. Global Others Sales YoY Growth (2016-2021) & (K Unit)
Figure 11. Global Acute Migraine Drugs Sales by Type (2016-2027) & (US$ Million)
Figure 12. Global Acute Migraine Drugs Sales Market Share in Volume by Type (2016-2021)
Figure 13. Global Acute Migraine Drugs Sales Market Share in Value by Type (2016-2021)
Figure 14. Global Acute Migraine Drugs Sales Market Share in Volume by Type (2022-2027)
Figure 15. Global Acute Migraine Drugs Sales Market Share in Value by Type (2022-2027)
Figure 16. North America Acute Migraine Drugs Sales Market Share in Volume by Type in 2020
Figure 17. North America Acute Migraine Drugs Sales Market Share in Value by Type in 2020
Figure 18. Europe Acute Migraine Drugs Sales Market Share in Volume by Type in 2020
Figure 19. Europe Acute Migraine Drugs Sales Market Share in Value by Type in 2020
Figure 20. Asia-Pacific Acute Migraine Drugs Sales Market Share in Volume by Type in 2020
Figure 21. Asia-Pacific Acute Migraine Drugs Sales Market Share in Value by Type in 2020
Figure 22. Latin America Acute Migraine Drugs Sales Market Share in Volume by Type in 2020
Figure 23. Latin America Acute Migraine Drugs Sales Market Share in Value by Type in 2020
Figure 24. Middle East and Africa Acute Migraine Drugs Sales Market Share in Volume by Type in 2020
Figure 25. Middle East and Africa Acute Migraine Drugs Sales Market Share in Value by Type in 2020
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Acute Migraine Drugs Sales in 2020
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Acute Migraine Drugs Revenue in 2020
Figure 28. Acute Migraine Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 29. Product Picture of Hospital Pharmacies
Figure 30. Global Hospital Pharmacies Sales YoY Growth (2016-2027) & (K Unit)
Figure 31. Product Picture of Drug Stores
Figure 32. Global Drug Stores Sales YoY Growth (2016-2027) & (K Unit)
Figure 33. Global Acute Migraine Drugs Sales by Application (2016-2027) & (US$ Million)
Figure 34. Global Acute Migraine Drugs Sales Market Share in Volume by Application (2016-2021)
Figure 35. Global Acute Migraine Drugs Sales Market Share in Value by Application (2016-2021)
Figure 36. Global Acute Migraine Drugs Sales Market Share in Volume by Application (2022-2027)
Figure 37. North America Acute Migraine Drugs Sales Market Share in Volume by Application in 2020
Figure 38. Latin America Acute Migraine Drugs Sales Market Share in Value by Application in 2020
Figure 39. Middle East and Africa Acute Migraine Drugs Sales Market Share in Value by Application in 2020
Figure 40. Key Raw Materials Price
Figure 41. Acute Migraine Drugs Manufacturing Cost Structure
Figure 42. Acute Migraine Drugs Industrial Chain Analysis
Figure 43. Channels of Distribution
Figure 44. Distributors Profiles
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed
Keyplayers in Global Acute Migraine Drugs Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
GSKTeva
Pfizer
Novartis
Sun Pharma
Grunenthal
Endo Pharmaceuticals
Merck
J & J